Stryker (SYK) Inventory Turnover Ratio, from third quarter 2026 to third quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 
Stryker Corp  (NYSE: SYK)
 

Stryker Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the third quarter 2026, Stryker's inventory turnover ratio sequentially decreased to 1.66 in the third quarter 2026, unsurprisingly, as the Stryker markets continue to deteriorate, and SYK's faces growing challenges to bring down its inventories. Stryker's average inventory processing period in the Sep 30 2026 quarter, has increased to 220 days, from 219 days, in the Jun 30 2026 quarter.

Within Healthcare sector 240 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the III Quarter 2026, to 1667, from total ranking in the second quarter 2026 at 1880.

SYK Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Stryker Corp Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

SYK Inventory Turnover Ratio (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Inventory Growth 7.02 % 4.39 % 6.15 % 11.23 % 1.47 %
Y / Y Cost of Sales Growth 3.04 % -4.13 % 4.15 % 12.42 % 11.53 %
Inventory Turnover Ratio (TTM) 1.66 1.67 1.71 1.72 1.71
SYK's Total Ranking # 1667 # 1880 # 1718 # 1728 # 1739
Average inventory processing period 220 218 214 212 214
Seq. Inventory Growth 4.09 % 1.88 % 2.05 % -1.12 % 1.53 %
Seq. Cost of Sales Growth 8.66 % -5.38 % -13.09 % 15.33 % 1.1 %




Inventory Turnover Ratio Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 107
Healthcare Sector # 241
Overall Market # 1667

Inventory Turnover Ratio Statistics
High Average Low
3 2.03 1.54
(Dec. 31. 2005)   (Dec 31 2020)



SYK Company Profile >> Back to SYK Efficiency Comparisons >> Compare SYK Inventory Turnover Ratio to its Competitors

Financial Statements
Stryker's Inventories $ 5,747 Millions Visit SYK's Balance sheet
Stryker's Cost of Revenues TTM $ 9,116 Millions Visit SYK's Income Statement
What are SYK's Sales? Visit SYK's Sales by Segment

Other Inventory Turnover Ratios
Stryker's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
SYK's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for SYK's Competitors
Inventory Turnover Ratio for SYK's Suppliers
Inventory Turnover Ratio for SYK's Customers

You may also want to know
SYK's Sales Growth Rates SYK's Pe Price to earnings ratio SYK's Receivables Turnover Ratio SYK's Stock Quote
SYK's Net Income Growth Rates SYK's Ps Price to Sales ratio SYK's Sales per Employee SYK's Asset Turnover Ratio
SYK's Net Margin SYK's Pb Price to Book ratio SYK's Financial Strength Ratios SYK's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Sep 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Sep 30 2026 Inventories at quarter ending Sep 30 2026
Medinotec Inc   4.28 $ 5.143  Millions$ 1  Millions
3m Company  4.02 $ 15,267.000  Millions$ 3,801  Millions
Novocure Limited  3.98 $ 166.721  Millions$ 42  Millions
Incyte Corporation  3.79 $ 439.399  Millions$ 116  Millions
Baxter International Inc   3.57 $ 8,117.000  Millions$ 2,277  Millions
Bausch Health Companies Inc   3.54 $ 4,518.000  Millions$ 1,276  Millions
Exelixis Inc   3.49 $ 93.324  Millions$ 27  Millions
Gilead Sciences Inc   3.30 $ 6,219.000  Millions$ 1,884  Millions
Mimedx Group Inc   2.98 $ 70.562  Millions$ 24  Millions
Ligand Pharmaceuticals Incorporated  2.93 $ 34.495  Millions$ 12  Millions
Neogen Corporation  2.89 $ 464.774  Millions$ 161  Millions
Biomerica Inc   2.65 $ 4.297  Millions$ 2  Millions
Dexcom Inc   2.65 $ 1,867.500  Millions$ 705  Millions
Angiodynamics Inc   2.50 $ 142.709  Millions$ 57  Millions
Pro dex Inc   2.45 $ 53.753  Millions$ 22  Millions
Illumina Inc   2.36 $ 1,458.000  Millions$ 618  Millions
Resmed Inc   2.33 $ 2,214.675  Millions$ 952  Millions
Beta Bionics Inc   2.31 $ 53.285  Millions$ 23  Millions
Merit Medical Systems Inc  2.25 $ 817.001  Millions$ 363  Millions
Johnson and Johnson  2.17 $ 32,222.000  Millions$ 14,824  Millions
Glaukos Corp  2.13 $ 131.180  Millions$ 62  Millions
Organon and Co   2.08 $ 2,859.000  Millions$ 1,371  Millions
Repligen Corp  2.07 $ 372.472  Millions$ 180  Millions
Bausch and Lomb Corp  2.01 $ 1,986.000  Millions$ 990  Millions
Clearpoint Neuro Inc   1.98 $ 17.564  Millions$ 9  Millions
Intuitive Surgical Inc   1.91 $ 3,799.300  Millions$ 1,986  Millions
Indivior Pharmaceuticals Inc   1.88 $ 208.000  Millions$ 111  Millions
Tenet Healthcare Corp  1.88 $ 642.000  Millions$ 342  Millions
Iradimed Corporation  1.78 $ 21.878  Millions$ 12  Millions
Insmed Inc  1.66 $ 237.067  Millions$ 143  Millions

Date modified: 2026-10-31T10:02:42+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.